Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

American Journal of Gastroenterology

Volumn 95, Issue 9, 2000, Pages 2218-2224

  Sørensen, Henrik Toft ^a   Mellemkjær, Lene ^b   Blot, William J ^c   Nielsen, Gunnar Lauge ^d   Steffensen, Flemming Hald ^e   McLaughlin, Joseph K ^c   Olsen, Jørgen H ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF AARHUS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DIGESTIVE SYSTEM HEMORRHAGE; ENTERIC COATED TABLET; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; STOMACH MUCOSA INJURY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; CONFIDENCE INTERVALS; DENMARK; DIAGNOSIS, DIFFERENTIAL; DRUGS, NON-PRESCRIPTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0033830067     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2000.02248.x     Document Type: Article

References (31)

1. Aspirin all round?
2. Aspirin and bleeding peptic ulcers in the elderly
3. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other non narcotic analgesics
4. Review article: Aspirin and gastrointestinal bleeding
5. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
6. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation
7. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
8. Risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary artery disease
9. Risks of upper GI bleeding during TIA prophylaxis with aspirin
10. Prophylactic aspirin and risk of peptic ulcer bleeding
11. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding
12. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
13. The gastrointestinal toxicity of aspirin: An overview of randomized controlled trials
14. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial
15. Thrombosis prevention trial: Randomised trial of low-density oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
16. Risk of major gastrointestinal bleeding with aspirin
17. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom
18. Acute upper gastrointestinal haemorrhage in west of Scotland: Case ascertainment study
19. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
20. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
21. The pharmacoepidemiologic prescription database of North Jutland - A valid tool in pharmacoepidemiological research
22. Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort
23. Descriptive tools and analysis
24. Regional administrative health registries as a resource in clinical epidemiology
25. The Danish Cancer Registry-History, content, quality and use
26. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man
27. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa
28. Aspirin-induced gastric mucosal damage: Prevention by enteric-coating and relation to prostaglandin synthesis
29. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding
30. Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale Database
31. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of anti-inflammatory drugs in Saskatchewan, Canada 1983